SIGLEC-3 (CD33) serves as an immune checkpoint receptor for HBV infection.

MLA

Tsai, Tsung-Yu, et al. “SIGLEC-3 (CD33) Serves as an Immune Checkpoint Receptor for HBV Infection.” The Journal of Clinical Investigation, vol. 131, no. 11, June 2021. EBSCOhost, https://doi.org/10.1172/JCI141965.

APA

Tsai, T.-Y., Huang, M.-T., Sung, P.-S., Peng, C.-Y., Tao, M.-H., Yang, H.-I., Chang, W.-C., Yang, A.-S., Yu, C.-M., Lin, Y.-P., Bau, C.-Y., Huang, C.-J., Pan, M.-H., Wu, C.-Y., Hsiao, C.-D., Yeh, Y.-H., Duan, S., Paulson, J. C., & Hsieh, S.-L. (2021). SIGLEC-3 (CD33) serves as an immune checkpoint receptor for HBV infection. The Journal of Clinical Investigation, 131(11). https://doi.org/10.1172/JCI141965

Chicago

Tsai, Tsung-Yu, Ming-Ting Huang, Pei-Shan Sung, Cheng-Yuan Peng, Mi-Hua Tao, Hwai-I Yang, Wei-Chiao Chang, et al. 2021. “SIGLEC-3 (CD33) Serves as an Immune Checkpoint Receptor for HBV Infection.” The Journal of Clinical Investigation 131 (11). doi:10.1172/JCI141965.